ArticleRheumatology and therapy2020

Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks.

Helena Marzo-Ortega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.